tirzepatide more effective than semaglutide vs Tirzepatide, which is better for you? Semaglutide vs Tirzepatide for Weight
Description
Some people may use protein shakes or nutrition drinks while taking GLP-1 medications, especially if they are having difficulty eating enough protein

Estos sntomas podran ser la manifestacin de deficiencias nutricionales y de la modulacin neuroqumica inducida por estos frmacos

The first phase 3 retatrutide trial, TRIUMPH-4, top-line data announced today Retatrutide, a triple GLP-1,GIP, glucagon agonist studied in patients with obesity and osteoarthritis 28.7% weight loss at 68 weeks Reduced key cardiometabolic risk markers non-HDL cholesterol, triglycerides, and hsCRP Highest dose lowered systolic BP by 14 mmHg Reduced WOMAC pain scores by up to an average of 4.5 points (75.8%) and significantly improved measures of physical function GI side effects most common adverse event We now await 7 additional phase 3 trials in other obesity related comorbidities

GLP-1 Orforglipron, FOUNDAYO semaglutide 72 9.6% tirzepatide 14.7%
Weight Loss Management GLP-1 Advanced Metabolic slows gastric emptying & promotes satiety, reducing appetite & food intake, which can lead to reduced caloric intake & increased fat burn

The injectable drug, initially only used as diabetes medication, is the first drug since Saxenda (2014) approved to treat chronic weight management in the 70% of American adults who are obese or overweight.
